Compare $GTBP vs $PTN | Chartloom

Compare

$GTBP vs $PTN

GT Biopharma Inc · Palatin Technologies Inc

GTBP

GT Biopharma Inc

PTN

Palatin Technologies Inc

Compare $GTBP vs $PTN

Comparing GT Biopharma Inc and Palatin Technologies Inc

GTBPGT Biopharma Inc

PTNPalatin Technologies Inc

GTBPGT Biopharma Inc

Market cap

$296M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-75.3%

FCF yield

-4.9%

PTNPalatin Technologies Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

3581.2%

YTD performance

-46.4%

52W performance

19.6%

FCF yield

-88.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTBP

PTN

Detailed metrics comparison

GTBP

GT Biopharma Inc

PTN

Palatin Technologies Inc

Market Cap

GTBP$296M

PTN$15M

Enterprise Value

GTBP$291M

PTN$8M

Price

GTBP$6.68

PTN$8.60

P/E Ratio

GTBPN/A

PTNN/A

P/S Ratio

GTBP174.71x

PTN1.16x

EV/Sales

GTBP95.98x

PTN0.59x

EV/EBITDA

GTBP0.00x

PTN0.18x

P/B Ratio

GTBP3.08x

PTN1.57x

P/FCF Ratio

GTBPN/A

PTNN/A

EV/FCF

GTBP-20.19x

PTN-0.58x

PEG Ratio

GTBPN/A

PTNN/A

Forward P/E (NTM)

GTBPN/A

PTNN/A

Forward P/S (NTM)

GTBPN/A

PTNN/A

Revenue (TTM)

GTBP$0

PTN$13M

Revenue Growth (YoY)

GTBPN/A

PTN3581.2%

Forward Rev Growth

GTBP216.5%

PTN-58.6%

Gross Margin (TTM)

GTBP36.5%

PTN97.8%

Operating Margin (TTM)

GTBP0.0%

PTN0.0%

EBITDA Margin (TTM)

GTBP0.0%

PTN-65.3%

Net Margin (TTM)

GTBP0.0%

PTN-63.5%

FCF Margin (TTM)

GTBPN/A

PTN-103.0%

Net Income (TTM)

GTBP$-33M

PTN$-8M

FCF (TTM)

GTBP$-14M

PTN$-14M

EPS (TTM)

GTBP-$21.10

PTN-$2.14

ROE (TTM)

GTBP-44308.0%

PTN-5370.0%

ROA (TTM)

GTBP-31311.0%

PTN-5808.0%

ROIC (TTM)

GTBP-44308.0%

PTN-5370.0%

Cash

GTBP$5M

PTN$7M

Debt

GTBP$0

PTN$0

Net Cash/Debt

GTBP$5M

PTN$7M

Current Ratio (TTM)

GTBP2.61x

PTN5.04x

Quick Ratio (TTM)

GTBP2.51x

PTN4.93x

Debt/Equity (TTM)

GTBP0.00x

PTN2.00x

Debt/Assets (TTM)

GTBP0.0%

PTN0.0%

Interest Coverage (TTM)

GTBPN/A

PTNN/A

Net Debt/EBITDA (TTM)

GTBP0.00x

PTN0.00x

Beta

GTBP0.81

PTN0.84

52W Performance

GTBP-75.3%

PTN19.6%

YTD Performance

GTBP-67.3%

PTN-46.4%

% from 52W High

GTBP-76.8%

PTN-72.3%

% from 52W Low

GTBP36.0%

PTN53.3%

Asset Turnover (TTM)

GTBP0.08x

PTN0.97x

FCF Yield (TTM)

GTBP-4.9%

PTN-88.7%

Earnings Yield (TTM)

GTBP-11.1%

PTN-54.7%

Dividend Yield (TTM)

GTBPN/A

PTNN/A

Rule of 40

GTBP0.0

PTN3,478.2

EV/GP/RG

GTBPN/A

PTNN/A

Ticker research

View GTBP research View PTN research

Metric	GTBP GT Biopharma Inc	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$296M	$15M
Enterprise Value	$291M	$8M
Price	$6.68	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	174.71x	1.16x
EV/Sales	95.98x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	3.08x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$13M
Revenue Growth (YoY)	N/A	3581.2%
Forward Rev Growth	216.5%	-58.6%
Profitability
Gross Margin (TTM)	36.5%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-65.3%
Net Margin (TTM)	0.0%	-63.5%
FCF Margin (TTM)	N/A	-103.0%
Net Income (TTM)	$-33M	$-8M
FCF (TTM)	$-14M	$-14M
EPS (TTM)	-$21.10	-$2.14
ROE (TTM)	-44308.0%	-5370.0%
ROA (TTM)	-31311.0%	-5808.0%
ROIC (TTM)	-44308.0%	-5370.0%
Financial Health
Cash	$5M	$7M
Debt	$0	$0
Net Cash/Debt	$5M	$7M
Current Ratio (TTM)	2.61x	5.04x
Quick Ratio (TTM)	2.51x	4.93x
Debt/Equity (TTM)	0.00x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.81	0.84
52W Performance	-75.3%	19.6%
YTD Performance	-67.3%	-46.4%
% from 52W High	-76.8%	-72.3%
% from 52W Low	36.0%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.97x
FCF Yield (TTM)	-4.9%	-88.7%
Earnings Yield (TTM)	-11.1%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View GTBP research	View PTN research

Valuation

P/S Ratio

PTN

1.16x

GTBP

174.71x

EV/FCF

GTBP

-20.19x

PTN

-0.58x

Growth & revenue

Revenue Growth TTM

PTN

3581.2%

Forward Revenue Growth

GTBP

216.5%

PTN

-58.6%

Profitability & performance

Gross Margin

PTN

97.8%

GTBP

36.5%

ROE

PTN

-5370.0%

GTBP

-44308.0%

FCF Yield %

GTBP

-4.9%

PTN

-88.7%

52-Week Performance

PTN

19.6%

GTBP

-75.3%

Detailed metrics comparison

GTBP

GT Biopharma Inc

PTN

Palatin Technologies Inc

Market Cap

GTBP$296M

PTN$15M

Enterprise Value

GTBP$291M

PTN$8M

Price

GTBP$6.68

PTN$8.60

P/E Ratio

GTBPN/A

PTNN/A

P/S Ratio

GTBP174.71x

PTN1.16x

EV/Sales

GTBP95.98x

PTN0.59x

EV/EBITDA

GTBP0.00x

PTN0.18x

P/B Ratio

GTBP3.08x

PTN1.57x

P/FCF Ratio

GTBPN/A

PTNN/A

EV/FCF

GTBP-20.19x

PTN-0.58x

PEG Ratio

GTBPN/A

PTNN/A

Forward P/E (NTM)

GTBPN/A

PTNN/A

Forward P/S (NTM)

GTBPN/A

PTNN/A

Revenue (TTM)

GTBP$0

PTN$13M

Revenue Growth (YoY)

GTBPN/A

PTN3581.2%

Forward Rev Growth

GTBP216.5%

PTN-58.6%

Gross Margin (TTM)

GTBP36.5%

PTN97.8%

Operating Margin (TTM)

GTBP0.0%

PTN0.0%

EBITDA Margin (TTM)

GTBP0.0%

PTN-65.3%

Net Margin (TTM)

GTBP0.0%

PTN-63.5%

FCF Margin (TTM)

GTBPN/A

PTN-103.0%

Net Income (TTM)

GTBP$-33M

PTN$-8M

FCF (TTM)

GTBP$-14M

PTN$-14M

EPS (TTM)

GTBP-$21.10

PTN-$2.14

ROE (TTM)

GTBP-44308.0%

PTN-5370.0%

ROA (TTM)

GTBP-31311.0%

PTN-5808.0%

ROIC (TTM)

GTBP-44308.0%

PTN-5370.0%

Cash

GTBP$5M

PTN$7M

Debt

GTBP$0

PTN$0

Net Cash/Debt

GTBP$5M

PTN$7M

Current Ratio (TTM)

GTBP2.61x

PTN5.04x

Quick Ratio (TTM)

GTBP2.51x

PTN4.93x

Debt/Equity (TTM)

GTBP0.00x

PTN2.00x

Debt/Assets (TTM)

GTBP0.0%

PTN0.0%

Interest Coverage (TTM)

GTBPN/A

PTNN/A

Net Debt/EBITDA (TTM)

GTBP0.00x

PTN0.00x

Beta

GTBP0.81

PTN0.84

52W Performance

GTBP-75.3%

PTN19.6%

YTD Performance

GTBP-67.3%

PTN-46.4%

% from 52W High

GTBP-76.8%

PTN-72.3%

% from 52W Low

GTBP36.0%

PTN53.3%

Asset Turnover (TTM)

GTBP0.08x

PTN0.97x

FCF Yield (TTM)

GTBP-4.9%

PTN-88.7%

Earnings Yield (TTM)

GTBP-11.1%

PTN-54.7%

Dividend Yield (TTM)

GTBPN/A

PTNN/A

Rule of 40

GTBP0.0

PTN3,478.2

EV/GP/RG

GTBPN/A

PTNN/A

Ticker research

View GTBP research View PTN research

Metric	GTBP GT Biopharma Inc	PTN Palatin Technologies Inc
Market & Valuation
Market Cap	$296M	$15M
Enterprise Value	$291M	$8M
Price	$6.68	$8.60
P/E Ratio	N/A	N/A
P/S Ratio	174.71x	1.16x
EV/Sales	95.98x	0.59x
EV/EBITDA	0.00x	0.18x
P/B Ratio	3.08x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-0.58x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$13M
Revenue Growth (YoY)	N/A	3581.2%
Forward Rev Growth	216.5%	-58.6%
Profitability
Gross Margin (TTM)	36.5%	97.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-65.3%
Net Margin (TTM)	0.0%	-63.5%
FCF Margin (TTM)	N/A	-103.0%
Net Income (TTM)	$-33M	$-8M
FCF (TTM)	$-14M	$-14M
EPS (TTM)	-$21.10	-$2.14
ROE (TTM)	-44308.0%	-5370.0%
ROA (TTM)	-31311.0%	-5808.0%
ROIC (TTM)	-44308.0%	-5370.0%
Financial Health
Cash	$5M	$7M
Debt	$0	$0
Net Cash/Debt	$5M	$7M
Current Ratio (TTM)	2.61x	5.04x
Quick Ratio (TTM)	2.51x	4.93x
Debt/Equity (TTM)	0.00x	2.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.81	0.84
52W Performance	-75.3%	19.6%
YTD Performance	-67.3%	-46.4%
% from 52W High	-76.8%	-72.3%
% from 52W Low	36.0%	53.3%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.97x
FCF Yield (TTM)	-4.9%	-88.7%
Earnings Yield (TTM)	-11.1%	-54.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,478.2
EV/GP/RG	N/A	N/A
Ticker research	View GTBP research	View PTN research